Cambridge Cognition (LON:COG) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Cambridge Cognition Holdings Plc (LON:COGGet Free Report)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 36.86 ($0.46) and traded as high as GBX 46 ($0.58). Cambridge Cognition shares last traded at GBX 46 ($0.58), with a volume of 8,962 shares.

Cambridge Cognition Trading Up 1.1 %

The firm has a market cap of £19.26 million, a P/E ratio of -12.22 and a beta of 0.72. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96. The firm has a fifty day simple moving average of GBX 39.26 and a 200-day simple moving average of GBX 36.86.

Insider Activity

In other Cambridge Cognition news, insider Stuart Gall acquired 31,250 shares of Cambridge Cognition stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average cost of GBX 32 ($0.40) per share, for a total transaction of £10,000 ($12,586.53). Also, insider Nick (Philip) Rodgers acquired 31,292 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The stock was purchased at an average cost of GBX 32 ($0.40) per share, with a total value of £10,013.44 ($12,603.45). Insiders own 29.89% of the company’s stock.

About Cambridge Cognition

(Get Free Report)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.

Read More

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.